Bandari Jathin's most recent trade in Protara Therapeutics Inc was a trade of 137,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protara Therapeutics Inc | Bandari Jathin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 137,000 | 137,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Bandari Jathin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 23,000 | 59,583 (1%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.91 per share. | 19 Jan 2024 | 2,879 | 56,704 (0%) | 0% | 1.9 | 5,499 | Common Stock |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 10 Jan 2024 | 1,877 | 36,583 (0%) | 0% | 2.4 | 4,486 | Common Stock |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 03 Jul 2023 | 682 | 38,460 (0%) | 0% | 2.5 | 1,678 | Common Stock |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 124,400 | 124,400 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 20,700 | 39,142 (0%) | 0% | 0 | Common Stock | |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 10 Jan 2023 | 1,876 | 18,442 (0%) | 0% | 3 | 5,628 | Common Stock |
| Protara Therapeutics Inc | Jathin Bandari | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.22 per share. | 01 Jul 2022 | 682 | 20,318 (0%) | 0% | 3.2 | 2,196 | Common Stock |